Livsmed Inc (KOSDAQ:491000)

South Korea · Delayed Price · Currency is KRW

41,950

0.00 (0.00%)

At close: Oct 21, 2026

Livsmed Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Revenue	52,819	51,192	27,121	17,267	9,678
Revenue Growth	37.01%	88.75%	57.07%	78.42%	-
Gross Profit	26,468	29,534	14,547	9,479	5,477
Operating Income	-31,108	-22,642	-26,504	-23,912	-17,090
Net Income	-26,540	-22,874	-25,585	-57,021	-59,019
Earnings Per Share	-1122.71	-1030.07	-1530.99	-4024.24	-4597.99
EPS Growth	-	-	-	-	-

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
South Korea	48,408	45,684	23,431	14,192	8,059
USA	1,886	3,067	2,110	1,691	705.8
Germany	986.14	962.26	740.63	507.51	368.47
Other	1,539	1,479	839.86	876.63	544.47
Total	52,819	51,192	27,121	17,267	9,678

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Investments	64,555	131,402	16,815	40,019	14,911
Total Debt	13,647	11,607	8,479	5,214	7,225
Net Cash (Debt)	50,908	119,795	8,336	34,804	7,686
Net Cash Growth	396.56%	1337.00%	-76.05%	352.82%	-
Net Cash Per Share	2152.86	5394.74	498.85	2456.31	598.79

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Operating Cash Flow	-45,349	-34,740	-27,664	-24,723	-17,881
Capital Expenditures	-37,422	-7,233	-4,345	-2,298	-654.24
Free Cash Flow	-82,771	-41,973	-32,009	-27,020	-18,535
Free Cash Flow Growth	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Gross Margin	50.11%	57.69%	53.64%	54.90%	56.59%
Operating Margin	-58.90%	-44.23%	-97.72%	-138.48%	-176.59%
Pretax Margin	-50.25%	-44.68%	-94.33%	-330.23%	-609.85%
Profit Margin	-50.25%	-44.68%	-94.34%	-330.23%	-609.85%
FCF Margin	-156.71%	-81.99%	-118.02%	-156.49%	-191.52%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct '26 Oct 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
PS Ratio	19.86	24.93	-	-	-